These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 1867322
21. Identification of novel antigens contributing to autoimmunity in cardiovascular diseases. Müller AM, Bockstahler M, Hristov G, Weiß C, Fischer A, Korkmaz-Icöz S, Giannitsis E, Poller W, Schultheiss HP, Katus HA, Kaya Z. Clin Immunol; 2016 Dec; 173():64-75. PubMed ID: 27634429 [Abstract] [Full Text] [Related]
22. [Dilated cardiomyopathy--a chronic myocarditis? Immunohistological characterization of lymphocytic infiltrates]. Kühl U, Daun B, Seeberg B, Schultheiss HP, Strauer BE. Herz; 1992 Apr; 17(2):97-106. PubMed ID: 1577368 [Abstract] [Full Text] [Related]
23. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. Shichi D, Kikkawa EF, Ota M, Katsuyama Y, Kimura A, Matsumori A, Kulski JK, Naruse TK, Inoko H. Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831 [Abstract] [Full Text] [Related]
24. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy. Wang Z, Liao Y, Dong J, Li S, Wang J, Fu ML. Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710 [Abstract] [Full Text] [Related]
25. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy. Caforio AL, Bauce B, Boffa GM, De Cian F, Angelini A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S, Thiene G, Dalla Volta S. G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945 [Abstract] [Full Text] [Related]
26. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? Caforio AL, Stewart JT, Bonifacio E, Burke M, Davies MJ, McKenna WJ, Bottazzo GF. J Autoimmun; 1990 Apr; 3(2):187-200. PubMed ID: 2187452 [Abstract] [Full Text] [Related]
27. Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. Seko Y, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, Kagawa N, Osada K, Suzuki S, Yagita H, Okumura K. J Clin Invest; 1995 Aug; 96(2):1035-41. PubMed ID: 7635939 [Abstract] [Full Text] [Related]
28. Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells. Pummerer CL, Grässl G, Sailer M, Bachmaier KW, Penninger JM, Neu N. Lab Invest; 1996 May; 74(5):845-52. PubMed ID: 8642780 [Abstract] [Full Text] [Related]
32. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. Neumann DA, Rose NR, Ansari AA, Herskowitz A. J Immunol; 1994 Jan 01; 152(1):343-50. PubMed ID: 8254202 [Abstract] [Full Text] [Related]
33. Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy. Okazaki T, Honjo T. Trends Mol Med; 2005 Jul 01; 11(7):322-6. PubMed ID: 15935731 [Abstract] [Full Text] [Related]
34. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S. Circulation; 1992 May 01; 85(5):1734-42. PubMed ID: 1533350 [Abstract] [Full Text] [Related]
35. Discovering novel targets for autoantibodies in dilated cardiomyopathy. Buse C, Altmann F, Amann B, Hauck SM, Poulsen Nautrup C, Ueffing M, Stangassinger M, Deeg CA. Electrophoresis; 2008 Mar 01; 29(6):1325-32. PubMed ID: 18288668 [Abstract] [Full Text] [Related]
37. [Ectopic expression and the significance of HLA-class II antigens in the myocardium in patients with dilated cardiomyopathy]. Li YY. Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Feb 01; 21(1):15-7, 62. PubMed ID: 8223147 [Abstract] [Full Text] [Related]
38. [The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory reaction]. Wilke A, Schönian U, Herzum M, Hengstenberg C, Hufnagel G, Brilla CG, Maisch B. Herz; 1995 Apr 01; 20(2):95-108. PubMed ID: 7774871 [Abstract] [Full Text] [Related]
39. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Landsberger M, Staudt A, Choudhury S, Trimpert C, Herda LR, Klingel K, Kandolf R, Schultheiss HP, Kroemer HK, Völker U, Felix SB. Am Heart J; 2008 Jul 01; 156(1):92-99.e2. PubMed ID: 18585502 [Abstract] [Full Text] [Related]
40. [Cardiac impairments induced by adoptive transfer of lymphocytes from the experimental cardiomyopathy in mice]. Yuan J, Liao YH, Wang ZH, Zhang JH, Tian Y, Dong JH, Wang JP. Zhonghua Yi Xue Za Zhi; 2005 Apr 06; 85(13):892-6. PubMed ID: 16029527 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]